...
【24h】

Pregnancy-Induced Sweet’s Syndrome Treated with Infliximab

机译:英夫利昔单抗治疗妊高征

获取原文

摘要

Objective: To present a case of relapsing and resistant Sweet’s syndrome that developed during pregnancy together with an onset of Crohn’s disease, showing complete resolution with the use of infliximab. Clinical Presentation and Intervention: A 30-year-old pregnant woman presented with fever, skin lesions, and diarrhea. Skin biopsy confirmed neutrophilic dermatosis and she was diagnosed with Crohn’s disease after endoscopy. There was no recurrence of Sweet’s syndrome outside of her pregnancy. During a previous pregnancy, while corticosteroids were ineffective, complete regression of skin lesions was achieved using infliximab. Conclusion: The “off-label” use of infliximab is beneficial for relapsing and resistant Sweet’s syndrome.
机译:目的:介绍一例在妊娠期间合并克罗恩病发作的复发性和耐药性甜食综合症,使用英夫利昔单抗即可完全解决。临床表现和干预措施:一名30岁的孕妇表现出发烧,皮肤病变和腹泻。皮肤活检证实为嗜中性皮肤病,经内镜检查后被诊断为克罗恩病。怀孕后,Sweet′s综合征没有复发。在先前的怀孕期间,尽管皮质类固醇激素无效,但使用英夫利昔单抗可以使皮肤病变完全消退。结论:英夫利昔单抗的“标签外”使用有益于复发和耐药的Sweet氏综合症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号